中文产业新闻评分60Chinese source
思璞锐 KRAS G12D(ON)抑制剂 SPR2015 以 21.3 亿美元授权给默沙东
21.3亿美元：思璞锐临床前KRAS G12D(ON)抑制剂授权给默沙东
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
21.3亿美元：思璞锐临床前KRAS G12D(ON)抑制剂授权给默沙东
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.